Lu jin ，MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of OCN19-overexpressed Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Refractory Type 2 Diabetes Mellitus (NCT06727721) | Lu jin ，MD | 2023-11-06 |
Track Lu jin ，MD automatically
Every clearance here is in the API, with alerts when new ones post.